dievini Hopp BioTech holding GmbH & Co KG - Jun 12, 2025 SCHEDULE 13D/A Report for CUREVAC N.V. Common Shares, par value (euro)0.12 per share (CVAC)

Filing Manager
dievini Hopp BioTech holding GmbH & Co KG
Reporting Manager
Dietmar Hopp
Security
CUREVAC N.V. Common Shares, par value (euro)0.12 per share
Symbol
CVAC
Shares outstanding
224M shares
Disclosed Ownership
82.4M shares
Ownership
36.7%
Form type
SCHEDULE 13D/A
Date filed
6/16/2025, 04:01 PM
Date of event
Jun 12, 2025
SEC
View on sec.gov

Reporting Managers (9)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
dievini Hopp BioTech holding GmbH & Co. KG 31.3% 70.2M 0 70.2M /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact 0001696029
DH-LT-Investments GmbH 3.9% 8.75M 0 8.75M /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact
DH-Capital GmbH & Co. KG 31.3% 70.2M 0 70.2M /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact
OH Beteiligungen GmbH & Co. KG 31.3% 70.2M 0 70.2M /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact
Dietmar Hopp 36.7% 82.4M 33.5K 82.3M /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder as attorney-in-fact
Oliver Hopp 31.3% 70.2M 0 70.2M /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder as attorney-in-fact
Daniel Hopp 31.3% 70.2M 0 70.2M /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder as attorney-in-fact
DHFS II Holding GmbH & Co. KG 3.9% 8.75M 0 8.75M /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact
Zweite DH Verwaltungs GmbH 1.5% 3.4M 0 3.4M /s/ Dr. Christina Eschenfelder Dr. Christina Eschenfelder/Attorney-in-fact